Ablation System, Short, 53 mm Jaw Size, Left Curve, Open, Sterile, Single-Use, For Isolator Synergy Ablation System, Treat Atrial Fibrillation During Heart Surgery, Intended to Ablate Cardiac Tissue for the Treatment of Persistent Afib
The Isolator Synergy ablation clamp is the first and only surgical ablation device offered with FDA approval for the treatment of Atrial Fibrillation (Afib) and the only device either catheter or surgical to be approved for the treatment of persistent and long-standing persistent Afib. The AtriCure Synergy ablation system is intended to ablate cardiac tissue for the treatment of persistent atrial fibrillation (sustained beyond seven days or lasting less than seven days but necessitating pharmacologic or electrical cardioversion) or longstanding persistent atrial fibrillation (continuous atrial fibrillation of greater than one year duration) in patients who are undergoing open concomitant coronary artery bypass grafting and/or valve replacement or repair.
